MiKO Pharma Limited is an emerging pharmaceutical manufacturing company making significant strides in Ghana’s healthcare and industrial landscape. The company is advancing plans to establish a state-of-the-art pharmaceutical manufacturing facility in the Akosombo-Akwamu area of the Eastern Region, which is set to become one of the largest and most advanced pharmaceutical plants in West Africa.

MiKO Pharma’s facility is designed to produce high-quality, affordable, WHO-compliant medications for a range of health conditions including high blood pressure, diabetes, heart disease, malaria, and pain management, helping to reduce reliance on imported drugs and improve access to essential medicines locally and across the continent. Through strategic partnerships with global firms such as Siemens and India-based Sushen Medicamentos Pvt. Ltd., the company is incorporating advanced pharmaceutical technology, robust production systems, and research-based formulations into its operations.

Beyond healthcare, MiKO Pharma’s growth is expected to have broader socio-economic benefits, including job creation, skills development, and local economic stimulation in the Eastern Region. The project also aligns with Ghana’s national agenda to strengthen local pharmaceutical manufacturing capacity and contribute to the global pharmaceutical supply chain.